Timeline for Judge's Ruling in ACLU's Anti-Gene Patenting Case Is Anybody's Guess | GenomeWeb

By Turna Ray

Following US District Court Judge Robert Sweet's decision earlier this month to not rule from the bench as to whether Myriad Genetics' BRCA gene patents are legally and constitutionally valid, it is anyone's guess as to when the judge may issue a determination on the case. Nevertheless, some legal experts predict that the judge may be waiting to decide the American Civil Liberties Union's anti-gene patenting case in order to see how the Supreme Court handles the method claims in Bilski v. Kappos.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.